Built for MedTech Organizations Rethinking What Their Internal Teams Should Own
Most MedTech organizations compare the cost of an outsourced resource to an FTE and conclude that building internally is more cost-effective. But that comparison does not account for idle capacity, ramp time, management overhead, or the revenue
impact of delayed submissions when a team that’s running lean
hits a surge event.
For functions that are A) operationally essential but not strategic differentiators, B) subject to variable demand, and C) require expertise that is difficult to maintain at full internal capacity, the math consistently favors an integrated partner. This tool kit gives MedTech organizations the frameworks to conduct a systematic evaluation and build an outsourcing model that delivers efficiency, speed, and reduced risk across the full product life cycle.
What’s Inside
- Executive brief making the financial and strategic case for outsourcing compliance-critical, nonrevenue-generating work
- Actual cost framework comparing what organizations typically count versus what a complete FTE-versus-outsourcing analysis really requires
- Outsource-or-own decision matrix for scoring any function across seven variables
- Life cycle outsourcing map showing where external partners add the most leverage
- Warning signs self-assessment for regulatory and quality leaders
- Partner evaluation checklist distinguishing strategic partners from functional vendors
- Surge readiness scorecard assessing whether your organization is positioned to respond to audit, remediation, and submission surge events proactively or reactively
Who This Is For
VPs and directors of regulatory affairs, quality, clinical operations, and finance at MedTech and IVD organizations evaluating their current outsourcing model or building the business case for a different one.
Get Your Copy Now
Fields marked with * are required.
